Observational study / 2011
Higher isoflavone intake from soy was associated with a decreased risk of death in early-stage breast cancer survivors.
Researchers examined the association between postdiagnosis soy isoflavone intake and breast cancer prognosis among 3,088 breast cancer survivors followed for a median of 7.3 years in the WHEL study. Isoflavone intake was measured using a food frequency questionnaire, and outcomes were verified by medical records or death certificates. As isoflavone intake increased, the risk of death decreased (P for trend = 0.02). Women in the highest intake category (>16.3 mg isoflavones) had a nonsignificant 54% reduction in risk of death.
Shows an association, not proof of cause and effect.
- Study type
- Prospective cohort study
- Who was studied
- 3,088 breast cancer survivors diagnosed between 1991 and 2000 with early-stage breast cancer (WHEL study)
- What was measured
- Second breast cancer event or death
THE PAPER
Soy food consumption and breast cancer prognosis.
Caan BJ, Natarajan L, Parker B, Gold EB, Thomson C, Newman V, Rock CL, Pu M, Al-Delaimy W, Pierce JP. Cancer Epidemiol Biomarkers Prev, 2011.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.